Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep;31(7):610-21.
doi: 10.1097/DBP.0b013e3181ef42c1.

Neurodevelopmental manifestations of mitochondrial disease

Affiliations
Review

Neurodevelopmental manifestations of mitochondrial disease

Marni J Falk. J Dev Behav Pediatr. 2010 Sep.

Abstract

Mitochondrial disease is an increasingly recognized but widely heterogeneous group of multisystemic disorders that commonly involve severe neurodevelopmental manifestations in childhood. This review explores the presentation, genetic basis, and diagnostic evaluation of primary mitochondrial disease. Emphasis is placed on neurodevelopmental findings that may be encountered by a Developmental Pediatrician that should provoke consideration of a mitochondrial disorder. The inheritance patterns and mechanisms by which mutations in genes located in either the nuclear or mitochondrial genomes can cause mitochondrial diseases are discussed. A general overview of the current diagnostic evaluation that can be readily initiated by the Developmental Pediatrician is provided, along with a summary of currently available treatment options.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1. Initiating the diagnostic evaluation for suspected mitochondrial disease
The Developmental Pediatrician can initiate a multi-faceted clinical and baseline laboratory evaluation to screen for multi-systemic involvement, including intermediary metabolic findings, which may support the diagnosis of mitochondrial disease. Abnormalities on these screening studies should prompt referral to a Metabolic disease specialist for further consideration of specific genetic and/or tissue studies (see text). *, since metabolic abnormalities may be seen only intermittently at the time of stress in mitochondrial disease, indicated blood and urine studies may need to be performed at baseline and then repeated at time of illness (i.e., fever or dehydration).

References

    1. Sanderson S, Green A, Preece MA, Burton H. The incidence of inherited metabolic disorders in the West Midlands, UK. Archives of disease in childhood. 2006;91:896–899. - PMC - PubMed
    1. Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorders--past, present and future. Biochimica et biophysica acta. 2004;1659:115–120. - PubMed
    1. Kriaucionis S, Paterson A, Curtis J, Guy J, Macleod N, Bird A. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol. 2006;26:5033–5042. - PMC - PubMed
    1. Lucke T, Hoppner W, Schmidt E, Illsinger S, Das AM. Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts. Molecular genetics and metabolism. 2004;82:93–97. - PubMed
    1. Luiro K, Kopra O, Blom T, Gentile M, Mitchison HM, Hovatta I, Tornquist K, Jalanko A. Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments. J Neurosci Res. 2006;84:1124–1138. - PubMed

MeSH terms

Substances